Primer
Biosimilars vs. Biologics: What’s the Difference and Why It Matters
Learn the key differences between biologics and biosimilars, how they compare on safety, effectiveness, regulation, and price, and what wider biosimilar uptake means for patient access and healthcare costs.
IPO, SPAC, or M&A? How Biotechs Go Public or Get Acquired
Demystify how small and mid-sized biotechs get acquired by big pharma, with a clear walkthrough of deal types, valuation drivers, milestones, and practical steps founders can take to become an attractive M&A target.